Novo Nordisk Share Repurchase Drives a 6.4% Rally
Can Novo Nordisk’s massive buyback and Wegovy pill momentum outweigh a fresh cyber threat and keep this rally alive? Maik Kemper Editor in Chief The Wegovy pill is…
Eli Lilly GLP-1 pill Foundayo: Can the Boom Last?
Can the new Eli Lilly GLP-1 pill Foundayo justify the stock’s rich valuation and extend its obesity drug dominance? Maik Kemper Editor in Chief Conclusion Overall, the Eli…